In adenovirus type 12 transformed cells, the down-regulation of MHC class I transcription contributes to the tumorigenic phenotype and is solely mediated by Ad12 E1A. Previous in vitro studies with class I enhancer sequences have indicated that there is an increased binding of repressor COUP-TFII and its associated HDAC and a decreased binding of activator NF-B. In this study, we used chromatin immunoprecipitation (ChIP) assay in order to determine in vivo whether these proteins regulate class I transcription by affecting chromatin. The ChIP assay revealed that there is lack of chromatin histone acetylation in the region of the class I enhancer in Ad12-transformed cells. This is regulated by histone deacetylation as it was further demonstrated in vivo that COUP-TFII and HDAC are associated with the class I enhancer chromatin. In agreement with in vitro studies, NF-B could be recruited to the class I enhancer following induction by TNF-␣. However, this enhancer-bound NF-B failed to up-regulate class I expression because the class I enhancer chromatin remained repressed as a result of histone deacetylation by HDAC in association with COUP-TFII. Thus, we have demonstrated for the first time that repression of chromatin through histone deacetylation is a major mechanism in down-regulating class I transcription in Ad12-transformed cells. Finally, Ad12 E1A, a non-DNA binding protein, was shown to be present in the natural protein complex bound to the class I enhancer.
Introduction
Cell surface major histocompatibility complex (MHC) class I antigens are important for cell-mediated immune surveillance carried out by cytotoxic T lymphocytes (CTLs). In cells transformed by adenovirus type 12 (Ad12), cell surface MHC class I antigens are diminished, which increases the tumorigenic potential of these transformed cells through avoidance of CTL detection Eager et al., 1985;  reviewed by Williams et al., 2002) . This reduction of class I antigen surface expression is due to the down-regulation of class I gene transcription and is solely mediated by effects of Ad12 E1A on the class I enhancer Vasavada et al., 1986; Ackrill and Blair, 1988; Friedman and Ricciard, 1988; . The class I enhancer contains a binding site (R1 site) for the transcription activator NF-B and a second binding site (R2 site) for nuclear hormone receptors (Kimura et al., 1986 ; reviewed by Williams et al., 2002) . In vitro studies have shown in Ad12-transformed cells that chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) binds to the R2 site and acts as a repressor of class I transcription Krali et al., 1992; Liu et al., 1994; Smirnov et al., 2001 ; see Fig. 1 ). One possible mechanism by which COUP-TFII exerts this repressive effect is through its association with histone deacetylases (HDACs), which function to repress transcription by modifying chromatin (Smirnov et al., 2000) . In addition, there is a loss of DNA binding activity of the transcription activator NF-B to the R1 site of the class I enhancer (Kushner et al., 1996; Liu et al., 1996; Hou et al., 2002; see Fig. 1) . Recent studies suggest that this increased binding of a repressor and decreased binding of an activator to the class I enhancer constitutes a "fail-safe" mechanism used by Ad12 E1A to ensure that class I transcription remains shut down under different physiological conditions .
While our previous in vitro studies convincingly indicated that presence of COUP-TFII and absence of NF-B are responsible for down-regulation of class I transcription, it remains essential to demonstrate in vivo if these factors are physiologically associated with the class I enhancer and to determine the mechanism by which they mediate transcriptional repression. In this study we approached this issue by employing chromatin-immunoprecipitation (ChIP) assay. Unlike conventional methods in measuring protein/ DNA interactions, e.g. electrophoretic mobility shift assay (EMSA) and transient transfection, the ChIP assay has the major advantage of permitting in vivo the examination of the interaction of promoter regions with protein complexes in the natural genomic state. In addition, ChIP assay provides a direct means to study the histone acetylation status of specific chromatin regions.
Here we demonstrate for the first time that the repressor COUP-TFII, but not activator NF-B, is physiologically associated with the class I enhancer, and that chromatin repression mediated by HDAC is a major mechanism for class I transcriptional down-regulation. Finally, Ad12 E1A, the viral mediator of class I transcription shut-off, is a component of the protein complex bound to the class I enhancer.
Results
There is lack of histone acetylation of the MHC class I enhancer in Ad12-transformed cells Transcription of MHC class I genes is shut down in tumorigenic Ad12-transformed cells (Ackrill and Blair, 1988; Friedman and Ricciard, 1988) and correlates with loss of binding of the activator NF-B and gain of binding of the repressor COUP-TFII to the class I enhancer Liu et al., 1996; Smirnov et al., 2001; Hou et al., 2002) . The direct converse of these activities is observed in non-tumorigenic Ad5-transformed cells. In this study, we wished to determine if chromatin repression is associated with loss of MHC class I transcription in Ad12 transformed cells, especially since our in vitro studies showed that an HDAC activity co-immunoprecipitated with COUP-TFII (Smirnov et al., 2000) . To address this question we measured the level of histone acetylation by employing antiacetyl histone antibodies in ChIP assay, since histone acetylation of chromatin is a hallmark of active transcription (Berger, 2001) . The MHC class I enhancers from the Ad12- and Ad5-transformed cells lines, 12A1 and KAd5 respectively, were examined. The 12A1 and KAd5 cell lines have been highly characterized and are representative of all Ad12 and Ad5 cells studied (Eager et al., 1985; Liu et al., 1994; Kushner et al., 1996; Liu et al., 1996; Smirnov et al., 2001) . Briefly, the ChIP assay was performed by incubating antibody with the supernatant of sonicated chromatin from cells treated with formaldehyde cross-linking reagent that preserves natural DNA/protein complexes (see Materials and methods). The immunoprecipitated chromatin fragments were amplified by PCR using specific oligonucleotide primers flanking the class I enhancer and visualized on an agarose gel. The PCR signal is thus an indication of the presence of a regulatory protein in a complex binding to the class I enhancer DNA. As shown in Fig. 2 , histone acetylation of the class I enhancer was detected only in the Ad5-transformed cell line (compare lanes 1 and 2). These in vivo results indicate that in Ad12-transformed cells, the chromatin in the region of the class I enhancer assumes a much less active state than that in Ad5-transformed cells. This is in accord with our in vitro studies which have shown that class I transcription is down-regulated in Ad12-transformed cells.
COUP-TFII and HDACs are present in a complex binding to the MHC class I enhancer in Ad12transformed cells
It was previously shown in vitro that the binding of COUP-TFII to the R2 site of the MHC class I enhancer is significant in Ad12 and negligible in Ad5-transformed cells Smirnov et al., 2001) , and that histone deacetylase activity is associated with COUP-TFII (Smirnov et al., 2000) . Since the above results and our previous in vitro studies suggest that histones associated with the class I enhancer region are deacetylated in Ad12-transformed cells, it was important to prove in vivo that COUP-TFII and HDACs are actually present on the class I en-hancer. A ChIP assay was performed using sonicated chromatin samples from KAd5 and 12A1 cells, and antibodies against COUP-TFII and HDAC4. As shown in Fig.  3A , both COUP-TFII and HDAC4 were found to be present on the class I enhancer in 12A1 cells (lanes 3 and 4), but not in KAd5 cells (lanes 1 and 2). An antibody against HDAC4 was used in Fig. 3A since it resulted in the strongest PCR signal among several HDAC family members tested, including HDAC4, HDAC5, HDAC6, and HDAC7 ( Fig. 3B ). It should be noted that although HDAC4 and HDAC5 are clearly present in the class I chromatin complex, the potential differences in antibody affinities make it difficult to determine if a particular HDAC species is dominant in the complex.
NF-B is recruited to the MHC class I enhancer in Ad12transformed cells following treatment with TNF-␣
Critical to transcriptional activation of the class I promoter is binding of NF-B (p50/p65) to the R1 site of the Fig. 3 . COUP-TFII and HDACs complex to the MHC Class I enhancer chromatin in Ad12-transformed cells. (A) Sonicated chromatin from Ad5transformed (KAd5) and Ad12-transformed (12A1) cells was immunoprecipitated with 5 l of anti-COUP-TFII (lanes 1 and 3) or anti-HDAC4 (lanes 2 and 4) antibodies or was used as a negative control with no antibody (lanes 5 and 6). Samples were then amplified by PCR using primers flanking the class I enhancer region, and PCR products were resolved on an agarose gel. To compare the relative amounts of chromatin used in the immunoprecipitation, 1% of input from each cell type was amplified by PCR, as shown at the bottom of the figure. (B) Sonicated chromatin from 12A1 cells was divided into 5 aliquots, each of which was then immunoprecipitated with anti-HDAC4 (5 l), anti-HDAC5 (20 l), anti-HDAC6 (20 l), anti-HDAC7 (20 l), or no antibody. Samples were then amplified by PCR using primers flanking the class I enhancer region, and PCR products were resolved on an agarose gel. These results are representative of multiple independent experiments. class I enhancer. DNA band-shift experiments have shown that binding of NF-B to the class I enhancer is strong in Ad5-transformed but is negligible in Ad12-transformed cells (Kushner et al., 1996; Liu et al., 1996; Hou et al., 2002) . Consistent with these in vitro findings, the ChIP assay confirms that there is a significantly greater presence of NF-B on the class I enhancer in Ad5-transformed cells than in Ad12-transformed cells (compare lanes 1 of Figs. 4A and 4B ). Also in agreement with previous findings that cytokines such as TNF-␣ can induce the binding of NF-B to the R1 oligonucleotide in Ad12-transformed cells, the ChIP assay demonstrates that NF-B is recruited to the class I enhancer in Ad12-transformed cells following treatment with TNF-␣ (Fig. 4B, lane 2) .
Class I enhancer chromatin repression by HDAC dominates activation by NF-B in Ad12-transformed cells
It is well known that TNF-␣ can stimulate NF-B DNA binding and transcriptional activation, in part, by mediating histone acetylation through coactivators containing histone acetyltransferase activity (Gerrritsen et al., 1997; Zhong et al., 1998; Sheppard et al., 1999) . As demonstrated above ( Fig. 4B ), in Ad12-transformed cells NF-B binding to the class I enhancer can be induced by TNF-␣. Interestingly, our earlier findings indicated that activated NF-B fails to up-regulate class I transcription in the presence of COUP-TFII and its associated HDAC (Smirnov et al., 2001; . However, the mechanism by which COUP-TFII/ HDAC prevents class I transcriptional activation by NF-B is not clear. To address this question, we investigated the status of chromatin histone acetylation of the class I enhancer following activation of NF-B by TNF-␣ and relief of COUP-TFII repression by the HDAC inhibitor TSA. As shown in Fig. 5 (lane 1) , there was negligible histone acetylation of the class I enhancer region in Ad12-transformed cells, as expected (Fig. 2, lane 2) . Interestingly, TNF-␣ treatment alone failed to increase histone acetylation of the class I enhancer region (Fig. 5, lane 3) . By contrast, the level of histone acetylation was significantly increased upon TSA treatment (lane 2). As compared to TSA treatment alone (lane 2), the combined treatment of TNF-␣ and TSA (lane 4) resulted in a discernible increase in the level of histone acetylation (ϳ40%, as determined by normalizing the signal from the various treatments against their respective 1% inputs). This histone acetylation can be reversed by removal of TSA, despite the constant presence of TNF-␣ (data not shown). These results indicate that COUP-TFII acts to repress class I transcription by mediating histone deacetylation through its interaction with HDAC. Moreover, this COUP-TFII mediated chromatin repression cannot be overcome solely by the recruitment of NF-B to the class I enhancer in Ad12-transformed cells. These findings provide an explanation for our previous Northern analyses showing that class I mRNA levels cannot be elevated by TNF-␣ treatment alone unless COUP-TFII repression is relieved .
Reduced class I surface expression by COUP-TFII and HDAC transcriptional repression can not be overcome by induced NF-B in Ad12-transformed cells
It is well established that in Ad12-transformed cells, the reduction of class I mRNA levels correlates with the lack of cell surface class I antigens Eager et al., 1985; Friedman and Ricciardi, 1988) . Here, we investigated by FACS analysis whether the ability to increase chromatin acetylation on the class I enhancer (Fig. 5 ) will lead to the elevation of class I surface antigen levels. As shown in Fig. 6 , treatment of 12-1 cells with TNF-␣, which recruits activator NF-B to the class I enhancer, failed to increase the levels of cell surface MHC class I antigens (compare panel 2 with 1). By contrast, treatment with TSA, which relieves the chromatin repression by HDAC, resulted in a substantial increase of cell surface class I antigens (Fig.  6, compare panel 3 , with 26.33% positively stained cells, and panel 1, with 0.86% positive cells). Finally, the combined treatment of TNF-␣ and TSA caused an even further increase of cell surface class I antigens (Fig. 6 , compare panel 4, with 49.79% positive cells, and panel 3, with 26.33% positive cells). These FACS results directly parallel those of the histone acetylation ChIP assay (Fig. 5 ) in that both chromatin repression and reduction of class I surface expression mediated by COUP-TFII and HDAC cannot be overcome by induced NF-B in Ad12-transformed cells. There is thus a link between regulation of class I transcription at the level of chromatin and the expression of class I antigens on the cell surface.
Ad12 E1A is present in class I enhancer complexes on both the repressed and activated chromatin
It has been demonstrated that the MHC class I shutdown in Ad12-transformed cells is mediated by E1A protein Vasavada et al., 1986) . However, it has never been shown whether Ad12 E1A, a protein which does not directly bind to DNA, is physically present in the complex bound to the MHC class I enhancer. As shown in Fig.  7 (lane 1) , a ChIP assay using Ad12 E1A-specific antibodies clearly indicated that Ad12 E1A is indeed a component of the protein complex bound to the class I enhancer. Following treatment with TNF-␣ and TSA, Ad12 E1A protein remained present in the complex that is bound to the class I enhancer (lane 2). Thus, Ad12 E1A is a part of class I enhancer complexes associated with both repressed and activated chromatin.
Discussion
One means by which adenovirus type 12 transformed cells attain tumorigenicity in immunocompetent host is to avoid CTL detection by diminishing MHC class I antigen expression Eager et al., 1985) . The only viral gene required to mediate this event is Ad12 E1A, which is responsible for the down-regulation of class I transcription by targeting the class I enhancer Vasavada et al., 1986) . In vitro studies indicated that repressor COUP-TFII is recruited to the class I enhancer and binding of activator NF-B is prevented Liu et al., 1996; Kushner et al., 1996; Smirnov et al., 2001; Hou et al., 2002) . Interestingly, while NF-B is induced to bind DNA by cytokine treatment of Ad12 transformed cells, it fails to overcome the class I transcriptional repression (Smirnov et al., 2001; Hou et al., 2002) .
These earlier in vitro results, employing EMSA, proved that COUP-TFII and NF-B have the potential to directly bind to specific class I enhancer oligonucleotides. However, EMSA is limited in that it does not measure protein associations in the natural context of chromatin. By contrast, ChIP assay is able to measure proteins associated with specific chromatin sequences under varying physiological conditions. Another advantage is that the cross-linking feature of the ChIP assay allows detection of proteins that bind directly to DNA, as well as non-DNA binding cofactors, such as HDAC, that are components of DNA-bound protein complexes. In addition, ChIP assay can also be used to detect histone acetylation of specific chromatin regions, which is a hallmark of chromatin activation.
By utilizing ChIP assay in this study, we provide in vivo evidence that COUP-TFII, but not NF-B, is associated with the class I enhancer in Ad12-transformed cells. Importantly, we show that COUP-TFII mediates down-regulation of class I transcription by recruiting HDAC to the class I enhancer. Moreover, we demonstrate definitively for the first time that repression of chromatin through histone deacetylation is a major mechanism in down-regulating class I transcription. This chromatin repression (ChIP assay, Fig. 5 ) and the resulting reduction of class I antigen expression (FACS analysis, Fig. 6 ) cannot be overcome solely by cytokine-induced activator NF-B, which is completely consistent with previous in vitro results. Finally, Ad12 E1A, a non-DNA binding protein, is shown by ChIP assay to be present in the natural protein complex bound to the class I enhancer.
The mechanism by which class I transcription is downregulated in Ad12-transformed cells appears to be unique. As seen in the model presented in Fig. 8 (panel A) , activator NF-B is present in the nucleus but fails to bind to the class I enhancer R1 site. COUP-TFII, bound to the R2 site of class I enhancer, is a novel negative regulator of class I transcription seen so far only in the Ad12-transformed cell system. In this study we demonstrated that COUP-TFII mediates repression of chromatin and class I transcription through its association with HDAC. Others have also suggested that COUP-TFII may negatively regulate transcription by contacting TFIIB, a component of the transcription initiation complex (Tsai and Tsai, 1997) . These two mechanisms of COUP-TFII repression are not mutually exclusive in that they may both play a role in class I down-regulation. Surprisingly, NF-B is induced by cytokines (TNF-␣ and IL-1␤) to bind to the class I enhancer, but is incapable of activating class I transcription (Fig. 8, panel B ). This is due to the strong negative effects exerted by COUP-TFII through histone deacetylation and chromatin repression. Verification of this dominant role of COUP-TFII can be seen when COUP-TFII-associated HDAC activity is inhibited by TSA, which permits histone acetylation, enabling NF-B to further activate class I transcription and surface expression by stimulating histone acetylation and the transcription initiation complex (Fig. 8, panel C) . This study thus provides an insight into the dynamics of class I transcriptional regulation in tumorigenic Ad12-transformed cells.
Finally, we have shown that Ad12 E1A, a non-DNA binding protein, is present on class I chromatin, presumably through protein-protein interaction. This is relevant since Ad12 E1A solely mediates the down-regulation of class I transcription. E1A is known to be a component of the mediator complex (Boyer et al., 1999) , and binds to p300 (Wang et al., 1993) , NF-B p50 subunit (Hou and Ricciardi, unpublished) , and transcription initiation proteins such as TAFs (Geisberg et al., 1995; Mazzarelli et al., 1997) . However, it remains to be determined how these E1A interac- Fig. 7 . Ad12 E1A is present in complexes bound to repressed and activated class I enhancer chromatin. Sonicated chromatin from Ad12-transformed (12A1) cells untreated (lane 1) or treated (100 nM TSA plus 10 ng/ml TNF-␣ for 1 h, lane 2) was immunoprecipitated with 5 l of anti-Ad12 E1A antibody or was used as a negative control with no antibody (lane 3). Samples were then amplified by PCR using primers flanking the class I enhancer region, and PCR products were resolved on an agarose gel. To compare the relative amounts of chromatin, 1% of input of untreated and treated cells was amplified by PCR, as shown at the bottom of the figure. This result is representative of multiple independent experiments. Fig. 8 . Model for the mechanism by which chromatin repression by COUP-TFII and HDAC dominates activator NF-B in regulating class I transcription in Ad12-transformed cells. A. In untreated cells, activator NF-B (p50/p65) fails to bind to class I enhancer DNA, while HDAC is recruited to the enhancer by repressor COUP-TFII to mediate histone deacetylation and chromatin repression, resulting in class I transcription shut-off. B. In TNF-␣ treated cells, even though activator NF-B is induced to bind to the class I enhancer, it fails to activate class I transcription due to chromatin repression mediated by COUP-TFII and HDAC. C. In TSA and TNF-␣ co-treated cells, the activity of HDAC is inhibited by TSA, which permits histone acetylation, enabling NF-B to further activate class I transcription by stimulating histone acetylation and the transcription initiation complex (TIC). tions influence class I transcription in Ad12-transformed cells.
Materials and methods

Cells, antibodies and reagents
Mouse Ad12-transformed cell line 12A1 and Ad5-transformed cell line KAd5, and rat Ad12-transformed cell line 12-1 were previously described (Eager et al., 1985; Jelinek et al., 1994) . Anti-p65 antibody was from Nancy Rice (National Cancer Institutes). Antibodies against COUP-TFII and 13S Ad12 E1A were previously described Scott et al., 1984) . Anti-HDAC4 and anti-acetylhistone antibodies were purchased from Upstate Biotech (Waltham, MA), and antibodies against HDAC5, 6, and 7 were purchased from Santa Cruz Biotech (Santa Cruz, CA). For treatment of cells, recombinant murine TNF-␣ was from R&D Systems Inc. and TSA was from Biomol (Plymouth Meeting, PA).
ChIP assay
ChIP assay was a modification of the protocol from Upstate Biotech. Cells from one 10 cm dish (approximately 1.5 ϫ 10 7 cells) were cross-linked by adding formaldehyde directly into the culture media to a final concentration of 1% and incubated at room temperature for 10 min. Media were then poured out, cells were then rinsed three times with PBS, scraped in PBS, and pelleted. Cell pellets were resuspended in 0.1 ml of the lysis buffer (included in the ChIP assay kit from Upstate Biotech), followed by adding 0.4 ml of the dilution buffer (included in the ChIP assay kit from Upstate Biotech). Cell lysates (1 ml) were sonicated 12 times for 30 sec each, at an energy level of 30% using a Sonifier Cell Disruptor (manufactured by Branson Sonic Power Inc., Danburg, CT). For ChIP assays performed with antiacetyl-histone antibody, cell lysates were sonicated only twice for 5 sec each. Sonicated chromatin samples were centrifuged for 2 min in a microcentrifuge. Supernatants (0.5 ml) were immunoprecipitated with antibodies (amount indicated in figure legends) and rotated at 4°C for a minimum of 3 h. Sixty microliters of protein-A agarose beads (50% slurry) were added to the supernatants and rotated for 30 min. The beads were then rinsed briefly in the low salt buffer (included in the ChIP assay kit from Upstate Biotech), washed for 5 min each in the high salt buffer and the LiCl buffer (included in the ChIP assay kit from Upstate Biotech), and finally rinsed briefly in TE. Immunoprecipitates were then resuspended in 0.5 ml of TE and 50 l of 2 M NaCl and DNA was eluted by reverse cross-linking at 65°C for a minimum of 1 h with occasional agitation. Eluated DNA was extracted with 0.5 ml of phenol/chloroform and ethanol-precipitated.
DNA pellets were resuspended in 50 l of water and were amplified by PCR. To compare the input of sonicated chromatin used in the ChIP assays, 1% of sonicated chromatin before immunoprecipitation was examined.
PCR amplification
The forward PCR primer (5Ј-GGGTTCAGGCAAAG-TCTTAG-3Ј) represents Ϫ211 to Ϫ231 of the mouse H2K d promoter region. The reverse PCR primer (5Ј-GACCT-GACCCAGGTTAGGTG-3Ј) represents Ϫ118 to Ϫ138 of the mouse H2K d promoter region. After 30 cycles, PCR reaction products (25 l) were resolved on a 1% agarose gel.
FACS analyses
FACS analyses were performed on a Becton Dickinson FACStarplus as previously described (Eager et al., 1985) . Anti-rat MHC class I monoclonal antibody RT1.A (OX-27) was purchased from Cedarlane Laboratories (Ontario, Canada).
